The #1 reason clinical trials fail isn't bad science — it's bad operations.

Here's what we keep seeing across biotech startups running Phase I-III trials:

Patient recruitment takes 2-3x longer than planned. Most teams rely on manual outreach and disconnected spreadsheets. By the time you realize enrollment is behind, you've burned months of runway.

Data collection is fragmented. CRFs in one system, adverse events in another, lab results emailed as PDFs. Your CRA spends more time chasing data than reviewing it.

Regulatory submissions become fire drills. When your data isn't clean and centralized from day one, every FDA interaction becomes a scramble to compile and reconcile.

The fix isn't hiring more people. It's having a single system that connects recruitment, EDC, protocol tracking, and compliance — so nothing falls through the cracks.

That's exactly what we built TrialFlow to do. One platform, built specifically for lean biotech teams running real trials.

If you're planning or running a trial right now, I'd genuinely love to hear what's slowing you down.